NCT02383849View on ClinicalTrials.gov

IMPAACT P1106: Pharmacokinetic Characteristics of Antiretrovirals and Tuberculosis Medicines in Low Birth Weight Infants

CompletedOBSERVATIONAL
Enrollment

124

Participants

Timeline

Start Date

August 4, 2015

Primary Completion Date

February 14, 2020

Study Completion Date

February 14, 2020

Conditions
Low-Birth-Weight InfantTuberculosisHIV
Trial Locations (2)

1862

Soweto IMPAACT CRS (8052), Johannesburg

7505

Family Clinical Research Unit (FAM-CRU) CRS (8950), Cape Town

All Listed Sponsors
collaborator

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

collaborator

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

NIH

lead

International Maternal Pediatric Adolescent AIDS Clinical Trials Group

NETWORK

NCT02383849 - IMPAACT P1106: Pharmacokinetic Characteristics of Antiretrovirals and Tuberculosis Medicines in Low Birth Weight Infants | Biotech Hunter | Biotech Hunter